Q4 2024 · 13F-HR
Propel Bio Management, LLCholdings as filed
Filed 2025-02-14 · accession 0001829126-25-000973
$100.7M
Reported value
21
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 72651A207 | PAGP | PLAINS GP HOLDINGS LP-CL | $23.4M | 23.2% | 1,272,360 | Common | SHARED |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS | $13.3M | 13.2% | 43,032 | Common | SHARED |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $9.6M | 9.50% | 343,729 | Common | SHARED |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $8.6M | 8.58% | 2,453,092 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $8.2M | 8.18% | 9,615,420 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS I | $8.0M | 7.98% | 989,927 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $6.3M | 6.30% | 2,087,139 | Common | SHARED |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $5.2M | 5.16% | 178,500 | Common | SHARED |
| 039697107 | ARDX | ARDELYX INC | $4.8M | 4.79% | 950,947 | Common | SHARED |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $3.5M | 3.45% | 624,022 | Common | SHARED |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS IN | $2.4M | 2.41% | 183,259 | Common | SHARED |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $2.3M | 2.25% | 56,359 | Common | SHARED |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $1.5M | 1.49% | 179,874 | Common | SHARED |
| 50127T109 | KURA | KURA ONCOLOGY INC | $1.1M | 1.12% | 130,000 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $875,821 | 0.87% | 1,492,792 | Common | SHARED |
| 28249U204 | 72C | EIGER BIOPHARMACEUTICALS | $765,000 | 0.76% | 146,381 | Common | SHARED |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $427,600 | 0.42% | 20,000 | Common | SHARED |
| 24661P807 | DCTH | DELCATH SYSTEMS INC | $204,680 | 0.20% | 17,000 | Common | SHARED |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $95,290 | 0.09% | 25,209 | Common | SHARED |
| F5888J116 | MATPF | MAAT PHARMA SACA | $25,082 | 0.02% | 3,151 | Common | SHARED |
| 169CVR016 | — | CHINOOK THERAPEUTICS | $9,750 | 0.01% | 79,357 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.